| RS2527506327 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527508309 |
HNRNPU
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 54 |
| RS2527520886 |
KDM5B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527528620 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527531235 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2527531294 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527531330 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527531361 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527531515 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2527531520 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2527531653 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527531679 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527531929 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527534967 |
ACTN2
|
Health Risk |
Likely pathogenic |
Intrinsic cardiomyopathy, Intrinsic cardiomyopathy |
| RS2527535553 |
KDM5B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527535804 |
KDM5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527536329 |
KDM5B
|
Health Risk |
Pathogenic |
— |
| RS2527542588 |
KDM5B
|
Health Risk |
Pathogenic |
— |
| RS2527549383 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527550514 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527550732 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527551269 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527554204 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527554344 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527554353 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS2527554359 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome, Usher syndrome |
| RS2527554370 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527554411 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527554452 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527554548 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Developmental delay, Developmental delay |
| RS2527555293 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527555688 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527557571 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527557595 |
ZBTB18
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527557851 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527559024 |
ZBTB18
|
Health Risk |
Pathogenic |
— |
| RS2527559893 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527560158 |
ZBTB18
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527560402 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527561061 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527561247 |
ZBTB18
|
Health Risk |
Likely pathogenic |
— |
| RS2527561443 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527561485 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527561619 |
ZBTB18
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 22 |
| RS2527561750 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS2527564762 |
KIF14
|
Health Risk |
Likely pathogenic |
Microcephaly 20, primary |
| RS2527564859 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527565001 |
KDM5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527565074 |
KDM5B
|
Health Risk |
Likely pathogenic |
KDM5B-related disorder, KDM5B-related disorder |
| RS2527565081 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527565495 |
KIF14
|
Health Risk |
Likely pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2527574499 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Primary familial hypertrophic cardiomyopathy |
| RS2527575471 |
SKI
|
Health Risk |
Pathogenic |
Shprintzen-Goldberg syndrome, Shprintzen-Goldberg syndrome |
| RS2527576538 |
KDM5B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527583101 |
KDM5B
|
Health Risk |
Likely pathogenic |
— |
| RS2527584557 |
ARV1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527587918 |
FASLG
|
Health Risk |
Pathogenic |
Autoimmune lymphoproliferative syndrome type 1, Autoimmune lymphoproliferative syndrome type 1 |
| RS2527596188 |
KIDINS220
|
Health Risk |
Pathogenic |
Ventriculomegaly and arthrogryposis, Ventriculomegaly and arthrogryposis |
| RS2527599063 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1AA, Dilated cardiomyopathy 1AA |
| RS2527606158 |
NPHS1
|
Health Risk |
Pathogenic |
Finnish congenital nephrotic syndrome, Finnish congenital nephrotic syndrome |
| RS2527606344 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527606425 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527606430 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527612631 |
COG2
|
Health Risk |
Pathogenic |
Congenital disorder of glycosylation, type IIq |
| RS2527614713 |
ACTN2
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1AA, Dilated cardiomyopathy 1AA |
| RS2527616593 |
GALNT2
|
Health Risk |
Likely pathogenic |
— |
| RS2527616848 |
KIDINS220
|
Health Risk |
Pathogenic |
Spastic paraplegia, intellectual disability |
| RS2527618828 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2527618864 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527618865 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS2527619261 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Usher syndrome type 2A |
| RS2527619264 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527619379 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2527622353 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2527622381 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2527622613 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527622805 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527622873 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527624286 |
ARV1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 38 |
| RS2527624366 |
ARV1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 38 |
| RS2527625216 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2527625308 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2527625515 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2527627635 |
KDM5B
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527627970 |
KDM5B
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 65 |
| RS2527635636 |
KDM5B
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2527645980 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2527645998 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2527646389 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2527646544 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527646571 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis |
| RS2527647145 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2527647307 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2527647377 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2527651949 |
KDM5B
|
Health Risk |
Likely pathogenic |
— |
| RS2527652567 |
WDR35
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 7 with or without polydactyly, Cranioectodermal dysplasia 2 |
| RS2527653482 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2527653911 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2527654049 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2527654082 |
USH2A
|
Health Risk |
Pathogenic |
— |